OUR MISSION is to ensure surviving lung cancer is the expectation, not the exception. OUR VISION: Double lung cancer survival by 2022. To turn this vision into reality, we focus on: Funding research with the greatest potential to save lives Helping all patients fully understand their treatment options Ensuring molecular tumor testing is standard of care Doubling the number of lung cancer patients participating in clinical trials